+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dsuvia"

United States DSUVIA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States DSUVIA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • United States
From
From
DSUVIA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

DSUVIA Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Dsuvia is an analgesic drug used to treat moderate to severe pain. It is a sublingual tablet that is administered under the tongue and is absorbed directly into the bloodstream. It is a Schedule II controlled substance and is only available through a restricted program. Dsuvia is a powerful opioid analgesic that is five to ten times more potent than fentanyl. It is intended for use in adults in a medically supervised setting, such as a hospital or emergency department. It is not intended for use at home or for chronic pain management. Dsuvia is part of a larger market of analgesics, which includes both prescription and over-the-counter medications. Common prescription analgesics include opioids, such as morphine and oxycodone, as well as non-opioid medications, such as ibuprofen and acetaminophen. Over-the-counter analgesics include ibuprofen, acetaminophen, and aspirin. Some companies in the analgesic market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Merck, and Novartis. Show Less Read more